Venu Pasricha

Venu Pasricha practices at Jefferson Einstein Philadelphia Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Venu Pasricha's NPI, 1063808921, was assigned on April 7, 2015. Venu Pasricha holds Pennsylvania license MD464318.

Venu Pasricha's primary practice is Jefferson Einstein Philadelphia Hospital, at 5501 Old York Road, Philadelphia, PA 19141 in Philadelphia County. The practice phone is (215) 456-6090.

Venu Pasricha's primary practice is Jefferson Einstein Philadelphia Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. Venu Pasricha is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is St. Luke's South Mountain Family Practice. Dmand AI also links Venu Pasricha to 2 more hospitals, 7 medical groups, 1 dialysis center and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Venu Pasricha practices, 6 sites in all. Vendor and product names are available with a free account.

Hospitalist is Venu Pasricha's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Venu Pasricha is licensed in Pennsylvania.

CMS data shows 1,476 Medicare services from Venu Pasricha across 5 procedure codes in 2024, for 543 Medicare patients. Medicare paid $115,053 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 543 Medicare patients who saw Venu Pasricha in 2024. The largest group is 75 to 84, with 232 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Venu Pasricha's median patient age at 78, with 45% women.

In 2024, Venu Pasricha wrote 628 Medicare Part D claims for 307 patients. 88% of them were for generic drugs. CMS names the drug for 351 of them, across 17 drugs with 11 or more claims each, at $17,083 in total drug cost. In 2023, CMS named 232 claims across 11 drugs.

Venu Pasricha accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Venu Pasricha, published from 2016 to 2020. Venu Pasricha's most frequent co-authors are Abhishek Bhardwaj, MD, Abhishek Bhardwaj, MD and Haroon Kamran, MD.

CMS Open Payments shows 101 general payments to Venu Pasricha from 16 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 95% of the total. Janssen Pharmaceuticals, Inc paid the most, $394.